Advanced search    

Search: authors:"Larry Radican"

7 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

A Survey of Patient Preferences for Oral Antihyperglycemic Therapy in Patients with Type 2 Diabetes Mellitus

employee of Merck Sharp & Dohme Corp. Charles M. Alexander is an employee of Merck Sharp & Dohme Corp. Michael J. Davies is an employee of Merck Sharp & Dohme Corp. Larry Radican is an employee of Merck

Assessment of severity and frequency of self-reported hypoglycemia on quality of life in patients with type 2 diabetes treated with oral antihyperglycemic agents: A survey study

Background Some oral antihyperglycemic agents may increase risk of hypoglycemia and thereby reduce patient quality of life. Our objective was to assess the impact of the severity and frequency of self-reported hypoglycemia on health-related quality of life (HRQoL) among patients with type 2 diabetes treated with oral antihyperglycemic agents. Findings A follow-up survey was...

Physician Reasons for Nonpharmacologic Treatment of Hyperglycemia in Older Patients Newly Diagnosed with Type 2 Diabetes Mellitus

Introduction To identify reasons why primary care physicians (PCPs) do not treat older patients newly diagnosed with type 2 diabetes mellitus (T2DM) with antihyperglycemic agents following diagnosis. Methods US PCPs were surveyed via the internet regarding their reasons for not treating patients aged >65 years diagnosed with T2DM and had not yet initiated antihyperglycemic...

Health Care and Productivity Costs Associated With Diabetic Patients With Macrovascular Comorbid Conditions

ALEX Z. FU PHD YING QIU PHD LARRY RADICAN PHD BRIAN J. WELLS MS E p i d e m i o l o g y / H e a l t h OBJECTIVE - To examine and quantify from the societal perspective the impact of macrovascular

Pre-existing cardiovascular diseases and glycemic control in patients with type 2 diabetes mellitus in Europe: a matched cohort study

Background Although there is a growing body of evidence showing that patients with type 2 diabetes mellitus (T2DM) have poor glycemic control in general, it is not clear whether T2DM patients with pre-existing cardiovascular diseases (CVD) are more or less likely to have good glycemic control than patients without pre-existing CVD. Our aim was to examine the degree of glycemic...

Effect of pill burden on dosing preferences, willingness to pay, and likely adherence among patients with type 2 diabetes

to finished article. Disclosure Steven Han, Ira Gantz, Kaan Tunceli, Kimberly Brodovicz, Charles M Alexander, Michael Davies, Kristy Iglay, Qiaoyi Zhang, and Larry Radican were employees of Merck

Multinational Internet-based survey of patient preference for newer oral or injectable Type 2 diabetes medication

Multinational Internet-based survey of patient preference for newer oral or injectable Type 2 diabetes medication Marco daCosta DiBonaventura1, Jan-Samuel Wagner1, Cynthia J Girman2, Kimberly Brodovicz2, Qiaoyi Zhang3, Ying Qiu3, Sri-Ram Pentakota3, Larry Radican31Health Sciences Practice, Kantar Health, New York; 2Epidemiology, 3Global Health Outcomes, Merck, Whitehouse Station...